Status:
UNKNOWN
Diagnostic Value of Sputum Cytology in Asthma-COPD Overlap
Lead Sponsor:
Assiut University
Conditions:
COPD, Asthma,ACO
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this study is to evaluate the diagnostic value of sputum cell counts in differentiation between asthma, COPD and ACO. to examine the relationship between sputum cell counts in bronchial re...
Detailed Description
Asthma and COPD are considered as chronic airway inflammatory diseases, which are typically associated with Th2-mediated immune response in asthma and related to the characteristics of Th1-mediated im...
Eligibility Criteria
Inclusion
- all patients known to be Asthma, COPD, ACO
Exclusion
- Patients will be excluded if they have confounding pulmonary comorbidities, such as pulmonary tuberculosis, interstitial lung disease, lung cancer or pulmonary infection, and had a cognitive impairment that may affect the collaboration or comprehension of the study.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04056364
Start Date
September 1 2019
End Date
October 1 2021
Last Update
September 20 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.